Rheologic & Vascular Modulators in Sickle Vasoocclusion

描述（由申请人提供）：我们假设镰状细胞性贫血中，血流动力学异常的来源不仅是异常的红细胞流变学（镰状化和粘附于内皮），而且是继发于内皮功能障碍的微血管控制紊乱。 该建议的重点是两个潜在的微血管流动和血管闭塞的镰状细胞贫血的调制器。 首先，响应于缺氧、机械损伤（红细胞镰状化和粘附）和氧化应激（继发于短暂性缺血发作）的内皮功能障碍将影响微血管系统响应流变学挑战的能力。 第二，红细胞与血管内皮的异常粘附不仅会导致内皮损伤，而且会导致周围环境的恶化。 本修订提案的目的是使用转基因和基因敲除镰状小鼠品系，在镰状背景下检查体内条件下异常流变学、氧化应激和血管张力之间的关系。 我们将测试以下具体假设：1）测试镰状化和伴随的血流异常（例如，短暂的血管闭塞事件）将导致氧化应激、微血管损伤和血管张力异常。 为了检验这一假设，我们将研究镰状化增强（缺氧）的影响，检查精氨酸补充的影响，并评估所选抗氧化剂的影响; 2）检验红细胞密度和聚合物形成的遗传和实验调节将影响内皮从而影响微血管功能的假设。 为了验证这一点，我们将确定抗镰状化胎儿血红蛋白和红细胞密度的实验调节的影响; 3）测试红细胞粘附在体内不仅有助于内皮损伤，但在微血管阻塞中起着至关重要的作用的假设。 为了验证这一假设，我们将重点关注内皮激活、特异性粘附分子、缺氧、NO、抗氧化剂的作用，并利用DNA微阵列技术鉴定粘附诱导因子调控的基因。拟议的研究涉及具有微循环、血液学、生物化学、细胞生物学和分子生物学专门知识的科学家的参与。 这些研究有望阐明与人类镰状细胞病相关的新机制，并具有潜在的治疗意义。

DESCRIPTION (provided by applicant): We hypothesize that in sickle cell anemia, the source of hemodynamic abnormalities is not only abnormal red cell rheology (sickling and adhesion to endothelium), but a derangement of microvascular controls secondary to endothelial dysfunction. This proposal focuses on two potential modulators of microvascular flow and vasoocclusion in sickle cell anemia. First, endothelial dysfunction in response to hypoxia, mechanical injury (red cell sickling and adhesion), and oxidative stress (secondary to transient ischemic episodes) would affect the ability of microvasculature to respond to rheological challenge. Second, abnormal adherence of red cells to vascular endothelium would not only result in endothelial injury, but also in a prosickling environment. The objective of this revised proposal is to examine the relationship between abnormal rheology, oxidative stress and vascular tone under in vivo conditions in the sickle context, using transgenic and knockout sickle mouse lines. We will test the following specific hypotheses: 1) Test the hypothesis that sickling and attendant flow abnormalities (e.g., transient vasoocclusive events) will cause oxidative stress, microvascular injury and vascular tone abnormalities. To test this hypothesis, we will investigate the effect of enhanced sickling (hypoxia), examine the effect of arginine supplementation, and evaluate the effect of selected anti-oxidants; 2) Test the hypothesis that genetic and experimental modulations of red cell density and polymer formation will impact endothelium and thereby microvascular function. To test this aspect, we will determine the effects of anti-sickling fetal hemoglobin and experimental modulations of red cell density; 3) Test the hypothesis that red cell adhesion in vivo not only contributes to endothelial injury but plays a crucial role in microvascular obstruction. To test this hypothesis, we will focus on the role of endothelial activation, specific adhesion molecules, hypoxia, NO, anti-oxidants, and use DNA microarray technology to identify genes regulated by adhesion inducing factors. The proposed research involves participation of scientists with expertise in microcirculation, hematology, biochemistry, cell biology and molecular biology. These studies are expected to elucidate new mechanisms with relevance to human sickle cell disease and with potential therapeutic implications.